Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Dermatology
•
General Dermatology
•
Pediatric Dermatology
In the era of targeted therapies, are there any specific cytokines that help guide therapy?
Related Questions
Would you recommend continuing Accutane in a teenage female who has experienced a drop in calcium to 8.8 and reductions in albumin and protein levels one month into therapy?
Have you encountered idiopathic aseptic facial granuloma in areas other than the face?
Do you pursue a cardiac evaluation in all patients with an excised cutaneous myxoma?
Is narrow-band ultraviolet B (nbUVB) phototherapy contraindicated or recommended with caution in patients with a personal history of melanoma?
How long can a patient with newly diagnosed merkel cell carcinoma wait for wide local excision with sentinel node biopsy?
How would you treat disseminated flat warts in an immunosuppressed patient with skin of color?
What is your approach to diagnosis and treatment to intermittent cheilitis that does not respond to anti fungal therapy?
How would you approach JAK inhibitors in pregnancy?
What are the best biologics for a pediatric patient with extensive guttate psoriasis that is poorly controlled on topicals?
What is your treatment approach for hidradenitis suppurativa?